Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes
C-reactive protein (CRP) is a pentraxin that has long been employed as a marker of inflammation in clinical practice. Recent findings brought up the idea of CRP to be not only a systemic marker but also a mediator of inflammation. New studies focused on structural changes of the plasma protein, reve...
Saved in:
Main Authors: | J. R. Thiele, J. Zeller, H. Bannasch, G. B. Stark, K. Peter, S. U. Eisenhardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2015/372432 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
C-Reactive Protein and Arteriosclerosis
by: Jan Torzewski, et al.
Published: (2014-01-01) -
C-Reactive Protein (CRP) and Autoimmune Disease: Facts and Conjectures
by: Alexander J. Szalai
Published: (2004-01-01) -
C-Reactive Protein and Cognition Are Unrelated to Leukoaraiosis
by: Liara Rizzi, et al.
Published: (2014-01-01) -
The Relationship between C-Reactive Protein/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease
by: Yi-Han Chen, et al.
Published: (2020-01-01) -
C-Reactive Protein (CRP) and Health Resort Reaction
by: Jadwiga Kuciel-Lewandowska, et al.
Published: (2020-01-01)